Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Minerva Chir ; 59(6): 563-72, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15876990

ABSTRACT

The management of patients with cervical injuries is highly controversial. Some authorities advocate mandatory exploration for all such injuries, while others advocate selective exploration. This paper will objectively review the evidence supporting each approach. The non-operative approach may be pursued through a variety of diagnostic modalities and this paper will also review the evidence supporting their use in cervical trauma. A clear understanding of these modalities and their relative merits is mandated by the potential severity of cervical injuries and their need for rapid intervention.


Subject(s)
Digestive System/injuries , Neck Injuries/surgery , Neck Injuries/therapy , Respiratory System/injuries , Clinical Trials as Topic , Drainage , Emergencies , Endoscopy , Esophageal Perforation/etiology , Esophagoscopy , Esophagus/injuries , Humans , Hypopharynx/injuries , Larynx/injuries , Neck Injuries/diagnosis , Neck Injuries/diagnostic imaging , Neck Injuries/etiology , Neck Injuries/mortality , Pharynx/injuries , Prospective Studies , Radiography, Thoracic , Risk Factors , Tomography, X-Ray Computed , Trachea/injuries , Tracheostomy
2.
J Adolesc Health ; 26(4): 258-67, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10734273

ABSTRACT

PURPOSE: To examine the development of HIV prevention strategies that address the concerns and needs of urban Puerto Rican adolescents. METHODS: The study included 542 Puerto-Rican adolescents, divided into age sets of 12 to 14 years and 15 to 19 years. Participants were recruited from community work programs, recreation centers, schools, drug rehabilitation programs, and directly from neighborhood streets in North Philadelphia. A hierarchical series of peer-facilitated group techniques and interviews allowed adolescents to generate, prioritize and explain strategies. The study question was developed in focus groups. Ideas were generated and prioritized in Nominal Technique Groups. The ideas with the highest priority were used to develop a survey that allowed participants to rank those they believed would be most effective. Participants then clarified the top-ranked ideas in open focus groups. RESULTS: In both age sets, the strategy perceived as the most effective in preventing HIV-risk behaviors was "Have people who are HIV-infected talk to teens." Similar ideas addressing this theme varied in perceived effectiveness. The second and third rated ideas among participants aged 12 to 14 years were "Teach teens how HIV infects them, " and "Show teens how people die from AIDS." The second and third rated ideas among participants aged 15 to 19 years were "Show teens what AIDS does to people " and "Have parents be more supportive of teens, so if they are having sex, they can encourage them to use condoms." Other top-ranked ideas included the development of community programs, increased efficacy and availability of condoms, and assessing partners for the risk of HIV infection. Three items revealed significant gender differences. Males were more likely to rate "Give out more free condoms" and "Educate teens in schools about AIDS." Females aged 15 to 19 years were more likely to rate "Teens should know their partner's background before having sex." CONCLUSIONS: To develop effective prevention strategies for youth, their views of the problems and interpretations of proposed solutions must be understood.


Subject(s)
Disease Transmission, Infectious/prevention & control , HIV Infections/prevention & control , HIV-1 , Hispanic or Latino , Poverty/ethnology , Urban Population , Adolescent , Adult , Disease Transmission, Infectious/statistics & numerical data , Female , Focus Groups , HIV Infections/ethnology , Health Knowledge, Attitudes, Practice , Hispanic or Latino/statistics & numerical data , Humans , Male , Philadelphia , Poverty/statistics & numerical data , Puerto Rico/ethnology , Surveys and Questionnaires , Urban Population/statistics & numerical data
3.
J Psychiatry Neurosci ; 24(2): 122-30, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10212554

ABSTRACT

OBJECTIVE: To determine whether indorenate, a serotonin-receptor agonist, can exert discriminative control over operant responses, to establish the temporal course of discriminative control and to compare its stimulus properties to a (5-HT)IA receptor agonist. [3H]-8-hydroxy-2-(di-N-propylamino) tetralin (8-OH-DPAT). DESIGN: Prospective animal study. ANIMALS: Ten male Wistar rats. INTERVENTIONS: Rats were trained to press either of 2 levers for sucrose solution according to a fixed ratio schedule, which was gradually increased. Rats were given injections of either indorenate or saline solution during discrimination training. Once they had achieved an 83% accuracy rate, rats underwent generalization tests after having received a different dose of indorenate, the training dose of indorenate at various intervals before the test, various doses of 8-OH-DPT, or NAN-190 administered before indorenate or 8-OH-DPAT. OUTCOME MEASURES: Distribution of responses between the 2 levers before the first reinforcer of the session, response rate for all the responses in the session, and a discrimination index that expressed the drug-appropriate responses as a proportion of the total responses. RESULTS: Indorenate administration resulted in discriminative control over operant responses, maintained at fixed ratio 10, at a dose of 10.0 mg/kg (but not 3.0 mg/kg). When the interval between the administration of indorenate and the start of the session was varied, the time course of its cue properties followed that of its described effects on 5-HT turnover. In generalization tests, the discrimination index was a function of the dose of indorenate employed; moreover, administration of 8-OH-DPAT (from 0.1 to 1.0 mg/kg) fully mimicked the stimulus properties of indorenate in a dose-dependent way. The (5-HT)IA antagonist NAN-190 prevented the stimulus generalization from indorenate to 8-OH-DPAT. Also, NAN-190 antagonized the stimulus control of indorenate when administered 45 minutes before the session, but not when administered 105 minutes before the session (i.e., 15 minutes before the administration of indorenate). CONCLUSION: (5-HT)IA receptors are of relevance to the stimulus function of indorenate. However, other receptor subtypes may also be involved. Hence, other agonists and specific antagonists should be studied before definite conclusions are drawn.


Subject(s)
5-Methoxytryptamine/analogs & derivatives , Discrimination, Psychological/drug effects , Serotonin Receptor Agonists/pharmacology , 5-Methoxytryptamine/pharmacology , 8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology , Animals , Male , Rats , Rats, Wistar , Receptors, Serotonin/drug effects , Receptors, Serotonin, 5-HT1
6.
Rev Esp Fisiol ; 39(3): 327-31, 1983 Sep.
Article in English | MEDLINE | ID: mdl-6658149

ABSTRACT

A method is described for determining triacylglyceride concentration in small amounts of plasma. After ethanolic-KOH digestion of diluted plasma aliquots, samples were neutralized with MgSO4 and glycerol was fluorimetrically assayed in supernatants by the coupling of glycerokinase, pyruvate kinase, and lactate dehydrogenase catalyzed reactions. Values were corrected by free glycerol present in the non-digested samples. Digestions were performed at different times and temperatures in order to establish optimum conditions for recoveries and reproducibility. Parallel determinations before and after phospholipid removal showed that their presence in plasma did not interfere with the obtained values. This method is especially useful for running many samples in parallel and for determinations in small experimental animals in which the amount of plasma is very limited.


Subject(s)
Triglycerides/blood , Fluorometry , Humans , Methods , NAD/analysis
7.
J Int Med Res ; 6(4): 257-65, 1978.
Article in English | MEDLINE | ID: mdl-357227

ABSTRACT

Amikacin was used in the treatment of various Gram-negative infections in sixty-six children ranging in age from two days to thirteen years. Over 72% of the infections treated were classified as severe and the remainder were moderate. Among infections in which the site of origin was the urinary or gastro-intestinal tract, amikacin achieved thirty-eight (95%) complete or partial cures in forty patients. In respiratory tract infections, amikacin completely or partially cured six (75%) out of eight patients. The remaining eighteen infections involved skin, soft tissue and other miscellaneous categories in which amikacin therapy resulted in seventeen (94%) complete or partial cures. Overall, amikacin achieved fifty-four complete cures and seven clinical or bacteriological cures in sixty-six patients, which represents an 82% complete cure rate and 10% partial cure rate for all the patients in the study.


Subject(s)
Amikacin/therapeutic use , Bacterial Infections/drug therapy , Kanamycin/analogs & derivatives , Adolescent , Amikacin/adverse effects , Child , Child, Preschool , Escherichia coli Infections/drug therapy , Female , Gastrointestinal Diseases/drug therapy , Humans , Infant , Infant, Newborn , Klebsiella Infections/drug therapy , Male , Respiratory Tract Infections/drug therapy , Skin Diseases/drug therapy , Urinary Tract Infections/drug therapy
8.
J Infect Dis ; 134 SUPPL: S406-11, 1976 Nov.
Article in English | MEDLINE | ID: mdl-993632

ABSTRACT

Thirty (86%) of 35 infants and older children with proven gram-negative sepsis had a complete clinical remission after treatment with amikacin. In 27 (82%) of 33 infectious episodes for which bacteriologic results were available before and after treatment, the organism was eradicated. The dosage of amikacin was either 7.5 mg/kg or 15 mg/kg given intramuscularly at 12-hr intervals. No adverse clinical effects or laboratory abnormalities were observed during treatment, which lasted from five to 14 days. All bacteria were sensitive to amikacin when tested by the disk diffusion method, and all but a single strain of Pseudomonas were sensitive when tested by the agar dilution method. Assays of serum and urine demonstrated adequate levels of amikacin after single intramuscular injections of 3.75 or 7.5 mg/kg; simultaneous assays of serum and cerebrospinal fluid in two cases demonstrated comparable concentrations of drug suggestive of a high degree of penetration into the cerebrospinal fluid in two cases demonstrated comparable concentrations of drug suggestive of a high degree of penetration into the cerebrospinal fluid during infection. Serial measurements of amikacin in serum from 0.5 to 12 hr after administration of single doses of 7.5 mg of drug/kg to six newborns revealed no significant differences in the concentrations achieved with intramuscular or intravenous administration of the drug.


Subject(s)
Amikacin/therapeutic use , Bacterial Infections/drug therapy , Infant, Newborn, Diseases/drug therapy , Kanamycin/analogs & derivatives , Adolescent , Amikacin/blood , Amikacin/pharmacology , Child , Child, Preschool , Enterobacteriaceae/drug effects , Enterobacteriaceae Infections/blood , Enterobacteriaceae Infections/drug therapy , Female , Humans , Infant , Infant, Newborn , Male , Microbial Sensitivity Tests , Pseudomonas/drug effects , Pseudomonas Infections/blood , Pseudomonas Infections/drug therapy
9.
J Int Med Res ; 4(1): 1-14, 1976.
Article in English | MEDLINE | ID: mdl-1026522

ABSTRACT

Thirty children over the age of one month were treated with amikacin (BBK8), a new aminoglycoside derived from kanamycin A, with three intramuscular dosage schedules. Each group consisted of ten patients. The first received 7-5 mg/kg/12 hours, the second 7-5 mg/kg/24 hours and the third, 3-75 mg/kg/12 hours. The infections and the bacteria were similar in all three groups: pyelonephritis, abscesses of soft tissues, infected wounds, septicaemia, superinfected empyema, gastro-enteritis, chronic otitis media; the bacteria were E. coli, Klebsiella, Pseudomonas and Salmonella. A were sensitive by the Kirby-Bauer method, although two were resistant by dilution in Petri dish. Of the thirty patients, twenty four (80%) were cured. The schedule of 3-75 mg/kg/12 hours was as effective as the schedule of 7-5 mg/kg/12 hours for infections such as pyelonephritis, superficial abscesses, contaminated wounds, gastro-enteritis and sepsis. The cases with infections localized in rather unaccessible sites required double the dose and strict drainage and cleanliness. Plasma levels with the administration of 3-75 mg/kg fluctuated between 8-3 and 12-6 mcg/ml; with 7-5 mg/kg they fluctuated between 8-6 and 13-1. The minimum inhibitory level (MIL) for the majority of the bacteria was 1-25 mcg/ml. No toxic reactions were observed.


Subject(s)
Amikacin/therapeutic use , Enterobacteriaceae Infections/drug therapy , Kanamycin/analogs & derivatives , Pseudomonas Infections/drug therapy , Adolescent , Amikacin/administration & dosage , Amikacin/metabolism , Child , Child, Preschool , Drug Administration Schedule , Drug Evaluation , Enterobacteriaceae Infections/metabolism , Female , Humans , Infant , Injections, Intramuscular , Male , Microbial Sensitivity Tests , Pseudomonas Infections/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...